2. Repository of UKIM
  3. Faculty of Medicine
  4. Faculty of Medicine: Journal Articles

Repository of UKIM


Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/8754
DC FieldValueLanguage
dc.contributor.authorKostov, Jorgoen_US
dc.contributor.authorDavceva-Pavlovska, Jelkaen_US
dc.contributor.authorKedev, Saskoen_US
dc.date.accessioned2020-08-12T09:48:34Z-
dc.date.available2020-08-12T09:48:34Z-
dc.date.issued2015-
dc.identifier.issn1857-9345-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/8754-
dc.description.abstractThe term acute coronary syndrome (ACS) refers to any group of clinical symptoms compatible with acute myocardial ischemia. These high-risk manifestations of coronary atherosclerosis are important causes of the use of emergency medical care and hospitalization. We evaluated the feasibility and the acute performance of the everolimus-eluting bioresorbable vascular scaffolds (BVS) for the treatment of patients presenting with ACS.en_US
dc.language.isoenen_US
dc.publisherMANU / Walter de Gruyter GmbHen_US
dc.relation.ispartofPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)en_US
dc.titleFirst Bioresorbable Vascular Scaffold Implantation in Patients with Acute Coronary Syndrome in the Republic of Macedoniaen_US
dc.typeArticleen_US
dc.identifier.doi10.1515/prilozi-2015-0063-
dc.identifier.urlhttp://content.sciendo.com/view/journals/prilozi/36/2/article-p147.xml-
dc.identifier.urlhttps://www.degruyter.com/view/j/prilozi.2015.36.issue-2/prilozi-2015-0063/prilozi-2015-0063.pdf-
dc.identifier.volume36-
dc.identifier.issue2-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

50
checked on Aug 8, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.